Back to search
FDAFDA · Food and drugs·Recall number D-1849-2019

Bevacizumab, 2.5 mg/0.1 mL, Norm-Ject Syringe Intravitreal Injection, Single use only, Rx only, Repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901

Published September 18, 2019 · Recall initiated: August 30, 2019

Summary

FDA records drug Class II recall D-1849-2019, published September 18, 2019 and initiated August 30, 2019. Recalling firm: Pacifico National, Inc. dba AmEx Pharmacy; Status: Terminated; Lot: All lots remaining within expiry. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of assurance of sterility.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pacifico National, Inc. dba AmEx Pharmacy
Distributor
Continental U.S. and Puerto Rico
Lot
All lots remaining within expiry.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Bevacizumab, 2.5 mg/0.1 mL, Norm-Ject Syringe Intravitreal Injection, Single use only, Rx only, Repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901 recalled?

Yes. FDA published recall D-1849-2019 on September 18, 2019. Reported hazard: Lack of assurance of sterility.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release